Literature DB >> 9163631

Compliance with nasal CPAP therapy for obstructive sleep apnoea: how much is enough?

W T McNicholas.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9163631     DOI： 10.1183/09031936.97.10050969

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

Review 1.  Interactions between obesity and obstructive sleep apnea: implications for treatment.

Authors:  Abel Romero-Corral; Sean M Caples; Francisco Lopez-Jimenez; Virend K Somers
Journal:  Chest       Date:  2010-03       Impact factor: 9.410

2.  Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis.

Authors:  J L Kiely; P Nolan; W T McNicholas
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139

Review 3.  Obstructive sleep apnoea/hypopnoea syndrome: relationship with obesity and management in obese patients.

Authors:  Giovanni Salzano; Fabio Maglitto; Antonella Bisogno; Luigi Angelo Vaira; Giacomo De Riu; Matteo Cavaliere; Arianna di Stadio; Massimo Mesolella; Gaetano Motta; Franco Ionna; Luigi Califano; Francesco Antonio Salzano
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

4.  Pressure modification or humidification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea.

Authors:  Barry Kennedy; Toby J Lasserson; Dariusz R Wozniak; Ian Smith
Journal:  Cochrane Database Syst Rev       Date:  2019-12-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.